首页 › 基金 › E. Ohman J:or Asset Management AB › CYTK

E. Ohman J:or Asset Management AB 对 CYTK 的持仓历史

CYTOKINETICS INC · 医疗保健

E. Ohman J:or Asset Management AB 在 Q3 2026 的 13F 申报中披露持有 CYTK(CYTOKINETICS INC)305,255 股,市值约 US$20.1M,约占其申报组合的 0.45%,在其申报持仓中市值排名第 47 位。 E. Ohman J:or Asset Management AB 最近 7 个申报季度中有 7 个季度披露了 CYTK 持仓,最早可追溯至 Q1 2025。

最新持仓 (Q3 2026)305.25K 股
申报持仓市值$20.12M
组合权重0.45%
首次申报Q1 2025
最近变动持有
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

E. Ohman J:or Asset Management AB 对 CYTK 的持仓演变

E. Ohman J:or Asset Management AB 于 Q1 2025 首次披露 CYTK 持仓:329,231 股(约 US$13.2M)。 该持仓在 Q2 2026 达到峰值 304,611 股,市值约 US$25.9M。 在 7 次申报中,E. Ohman J:or Asset Management AB 2 次增持、2 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 305,255 股、市值约 US$20.1M。

逐季持仓明细

季度股数金额变化
Q1 2025 329.23K $13.23M 新进
Q2 2025 407.04K $13.45M 增持
Q3 2025 407.04K $22.37M 持有
Q4 2025 362.96K $23.06M 减持
Q1 2026 300.76K $19.82M 减持
Q2 2026 304.61K $25.95M 增持
Q3 2026 305.25K $20.12M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CYTK 与 13F 数据

CYTK(CYTOKINETICS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 CYTK,申报仓位最大的包括:T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CYTK 的基金

查看 CYTK 的全部基金持有人 →

常见问题

How long has E. Ohman J:or Asset Management AB held CYTK?

E. Ohman J:or Asset Management AB has disclosed CYTK holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is E. Ohman J:or Asset Management AB's current position in CYTK?

As of Q3 2026, E. Ohman J:or Asset Management AB holds 305.25K shares of CYTK (CYTOKINETICS INC), valued at $20.12M, representing 0.45% of its reported portfolio and ranking #47.

Has E. Ohman J:or Asset Management AB been buying or selling CYTK?

In the latest 13F filing (Q3 2026), E. Ohman J:or Asset Management AB held unchanged its position in CYTK. The position peaked in Q2 2026 at 304.61K shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.